NYSE:ADCT

Adc Therapeutics Stock Forecast

etoro logo Buy ADCT
*Your capital is at risk
$3.08
-0.0900 (-2.84%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of ADCT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ADCT to Watchlist?
Some Reasons Why To Add ADCT:
  • High gross margin of 90.7%
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong return on equity of 65.3%
PDF

Adc Therapeutics Ltd stock price down 2.84% on Wednesday
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Apr 27, 2026 Loss -18.09%

The Adc Therapeutics Ltd stock price fell by -2.84% on the last day (Wednesday, 3rd Jun 2026) from $3.17 to $3.08. During the last trading day the stock fluctuated 5.30% from a day low at $3.02 to a day high of $3.18. The price has fallen in 5 of the last 10 days and is down by -1.91% for this period. Volume has increased on the last day by 290 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $3.23 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.92 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -20.40% during the next 3 months and, with a 90% probability hold a price between $2.32 and $3.14 at the end of this 3-month period.

ADCT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Adc Therapeutics Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.35 and $3.65. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 16, 2026, and so far it has fallen -29.68%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Adc Therapeutics Ltd stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.160 between high and low, or 5.30%. For the last week, the stock has had daily average volatility of 4.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADCT) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Adc Therapeutics Ltd to open at $3.09, and during the day (based on 14 day Average True Range), to move between $2.99 and $3.17, which gives a possible trading interval of +/-$0.185 (+/-6.20%) up or down from last closing price. If Adc Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 6.20% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.48, some $0.400 (12.99%) from the current price of $3.08, our system finds the risk reward not very attractive.

Is Adc Therapeutics Ltd stock A Buy?

Adc Therapeutics Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.613 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $3.09 ( 0.433%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ADCT Performance

Trading levels for ADCT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.25 5.63%
R2 3.19 3.64%
R1 3.15 2.42%
Price 3.08
S1 3.03 -1.55%
S2 2.99 -2.78%
S3 2.93 -4.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.78 22.73%
R2 3.76 22.08%
R1 3.48 12.99%
Price 3.08
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Adc Therapeutics Ltd Stock and on which exchange is it traded?
The symbol for Adc Therapeutics Ltd is ADCT and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Adc Therapeutics Ltd Stock?
Adc Therapeutics Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Adc Therapeutics Ltd Stock?
Adc Therapeutics Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adc Therapeutics Ltd Stock.

What's the current price of Adc Therapeutics Ltd Stock?
As of the end of day on the Jun 03, 2026, the price of an Adc Therapeutics Ltd (ADCT) share was $3.08.

What is the 52-week high and low for Adc Therapeutics Ltd Stock?
The 52-week high for Adc Therapeutics Ltd Stock is $4.97 and the 52-week low is $2.56.

What is the market capitalization of Adc Therapeutics Ltd Stock?
As of the Jun 03, 2026, the market capitalization of Adc Therapeutics Ltd is 391.748M.

When is the next earnings date for Adc Therapeutics Ltd?
The upcoming earnings date for Adc Therapeutics Ltd is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT ADC THERAPEUTICS LTD
Adc Therapeutics
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE